vTv Therapeutics (VTVT) Interest Coverage Ratio Growth (3y) (2017 - 2025)
Powered by 
Analysis
vTv Therapeutics (VTVT) Interest Coverage Ratio Growth (3y) (2017 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | -1.75% |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | - |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | 7.51% |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | - |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | 26.54% |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | - |
| 8 | BeOne Medicines | 40.49 Bn | 35.39 Bn | 1.53 Bn | - |
| 9 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | 59.44% |
| 10 | vTv Therapeutics | 413.85 Mn | 413.85 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -95.38% |
| Sep 30, 2025 | -44.37% |
| Dec 31, 2023 | -198.58% |
| Sep 30, 2023 | -381.11% |
| Jun 30, 2023 | -495.55% |
| Dec 31, 2022 | -260.46% |
| Sep 30, 2022 | -275.53% |
| Mar 31, 2022 | -881.80% |
| Dec 31, 2021 | -1,476.65% |
| Sep 30, 2021 | -429.30% |
| Dec 31, 2020 | 56.35% |
| Sep 30, 2020 | 3.94% |
| Jun 30, 2020 | -7.69% |
| Mar 31, 2020 | -17.15% |
| Dec 31, 2019 | 12.51% |
| Jun 30, 2019 | 91.40% |
| Mar 31, 2019 | 89.96% |
| Sep 30, 2018 | 60.29% |
| Jun 30, 2018 | -1.07% |
| Mar 31, 2018 | 16.02% |